Inside a Seattle lab working to develop a COVID-19 vaccine

‘We’ve put a lot of projects on hold so that we can focus on this.’

 

In a tall building on the outskirts of downtown Seattle, a group of scientists from the University of Washington’s Institute for Protein Design huddle in front of computers, concentrating on their screens. Using a special program, they’re tinkering with building blocks of proteins, taking the first of many steps to develop a vaccine for the new coronavirus, SARS-CoV-2.

Creating a working vaccine is challenging and will likely take over a year, at best. But with Seattle at the heart of the coronavirus outbreak in the U.S. — as of March 13, the state had seen 568 cases and 37 deaths, numbers almost certain to rise as more people are tested — this task is the top priority for the scientists. “We’ve put a lot of projects on hold so that we can focus on this,” said Brooke Fiala, a vaccine researcher who leads the institute’s nanoparticle laboratory. 

Promising proteins designed on a computer are then tested in the lab at the University of Washington’s Institute for Protein Design. The coronavirus vaccine will consist of a nanoparticle, formed from many interlocking proteins.
Ian C Haydon/Institute for Protein Design

In order to fight the coronavirus, scientists from universities and drug companies around the world are developing vaccines, using a variety of methods. Some labs are manipulating the early stages of protein development, while others are working with dead versions of the virus. Fiala and her colleagues are taking a different approach: manufacturing nanoparticles to create a more efficient vaccine.

Vaccines expose the body to an antigen, which is a small dose of virus or bacteria parts. The antigens trigger an immune response: The body’s immune cells produce antibodies, which combat the invader and protect against further infection. There are several ways to create a vaccine. In one common method, for example, scientists weaken the virus so that it reproduces very poorly once inside the body, giving the immune system time to make antibodies.

In Fiala’s lab, scientists are instead attempting to form what is called a nanoparticle. The shape of this microscopic particle must allow for an antigen called a spike protein — the part of the SARS-CoV-2 virus that allows it to infect human cells — to fuse to the outside. If all the pieces fit together properly, the resulting molecule should look like a spiky ball, with the nanoparticle at the core and the spike proteins protruding outward. Once perfected, this spiky ball can become a vehicle for introducing the viral proteins to human cells and stimulating the immune system.

The first step in making a nanoparticle vaccine involves designing a promising nanoparticle model using a computer, manufacturing the DNA that codes for its shape, and then transferring that DNA into E. coli bacteria. The bacteria follow the DNA’s instructions to form the correct protein. Researchers then burst open the bacteria and extract the newly made protein, which spontaneously folds into the desired nanoparticle — each piece of the molecule exactly where it should be. Finally, multiple spike proteins are attached to the outside of the nanoparticle, creating the spiky ball. The immune system reads repetitive arrangements like this as a sign of peril and responds by rapidly creating antibodies.

This type of vaccine is thought to be more powerful than other varieties; the nanoparticle is highly effective at stabilizing the spike proteins and inducing an immune response. And while it’s been in use since around the 1980s, engineering a nanoparticle on a computer is a big step forward. “The use of computational models to predict and design self-assembling proteins is a recent breakthrough in nanoparticle vaccine design,” said Emma Kate Loveday, a virologist at Montana State University.

It’s a complicated process, but after a recent success in generating a nanoparticle vaccine for respiratory syncytial virus, a contagious respiratory infection, Fiala is hopeful. “We’ve become quite practiced,” she said. “We’re very used to this process of taking those antigens and putting them on nanoparticles.” So far, they have ordered 18 different nanoparticle DNA sequences and are confident that one of these variations will eventually lead to a successful vaccine. 

In the upcoming months, the team hopes to get a vaccine to animal trials. If all goes well, the vaccine will then be tested in humans. Making sure it’s safe and effective enough for widespread use could take a year or longer, though. Science often appears to move at a frustratingly slow rate, especially when something as serious as the coronavirus is spreading so quickly, said Ian Haydon, the scientific communications manager for the Institute of Protein Design. “But science like this needs to move slowly in order to make the proper drugs to save lives.”

Helen Santoro is an editorial fellow at High Country News. Email her at [email protected] or submit a letter to the editor.

High Country News Classifieds
  • MARKETING COMMUNICATIONS MANAGER
    High Country News, an award-winning media organization covering the communities and environment of the Western United States, seeks a Marketing Communications Manager to join our...
  • EDITOR-IN-CHIEF
    High Country News, an award-winning media organization covering the communities and environment of the Western United States, seeks an Editor-In-Chief to join our senior team...
  • RESEARCH FELLOW (SOUTHWESTERN U.S. ENERGY TRANSITION)
    The Institute for Energy Economics and Financial Analysis (IEEFA) in partnership with the Grand Canyon Trust is seeking a full-time Fellow to conduct topical research...
  • LENDER OWNED FIX & FLIP
    2 houses on 37+ acres. Gated subdivision, Penrose Colorado. $400k. Possible lender financing. Bob Kunkler Brokers Welcome.
  • ONCE OR TWICE
    A short historical novel set in central Oregon based on the the WWII Japanese high altitude ballon that exploded causing civilian casualties. A riveting look...
  • HISTORIC LODGE AND RESTAURANT - FULLY EQUIPPED
    Built in 1901, The Crazy Mountain Inn has 11 guest rooms in a town-center building on 7 city lots (.58 acres). The inn and restaurant...
  • HOUSE FOR SALE
    Rare mountain property, borders National Forest, stream nearby. Pumicecrete, solar net metering, radiant heat, fine cabinets, attic space to expand, patio, garden, wildlife, insulated garage,...
  • COMMUNITY ORGANIZER- NORTHERN PLAINS RESOURCE COUNCIL
    Want to organize people to protect Montana's water quality, family farms and ranches, & unique quality of life with Northern Plains Resource Council? Apply now-...
  • CONSERVATION MANAGER
    The Rio Grande Headwaters Land Trust (RiGHT) is hiring an energetic and motivated Conservation Manager to develop and complete new conservation projects and work within...
  • POLLINATOR OASIS
    Seeking an experienced, hardworking partner to help restore a desert watershed/wetland while also creating a pollinator oasis at the mouth of an upland canyon. Compensation:...
  • ELLIE SAYS IT'S SAFE! A GUIDE DOG'S JOURNEY THROUGH LIFE
    by Don Hagedorn. A story of how lives of the visually impaired are improved through the love and courage of guide dogs. Available on Amazon.
  • COMING TO TUCSON?
    Popular vacation house, furnished, 2 bed/1 bath, yard, dog-friendly. Lee at [email protected] or 520-791-9246.
  • NORTHEASTERN UNIVERSITY
    All positions available: Sales Representative, Accountant and Administrative Assistant. As part of our expansion program, our University is looking for part time work from home...
  • RUBY, ARIZONA CARETAKER
    S. Az ghost town seeking full-time caretaker. Contact [email protected] for details.
  • EXECUTIVE DIRECTOR
    Powder River Basin Resource Council, a progressive non-profit conservation organization based in Sheridan, Wyoming, seeks an Executive Director, preferably with grassroots organizing experience, excellent communication...
  • ADOBE HOME
    Passive solar adobe home in high desert of central New Mexico. Located on a 10,000 acre cattle ranch.
  • EXECUTIVE DIRECTOR
    Eastern Nevada Landscape Coalition, based in Ely, Nevada is looking for a new executive director to replace the long-time executive director who is retiring at...
  • STEVE HARRIS, EXPERIENCED PUBLIC LANDS/ENVIRONMENTAL ATTORNEY
    Comment Letters - Admin Appeals - Federal & State Litigation - FOIA -
  • LISA MACKEY PHOTOGRAPHY
    Fine Art Gicle Printing. Photo papers, fine art papers, canvas. Widths up to 44". Art printing by an artist.
  • LOG HOME IN THE GILA WILDERNESS
    Beautiful hand built log home in the heart of the Gila Wilderness on five acres. Please email for PDF of pictures and a full description.